Stock Price
84.15
Daily Change
4.43 5.56%
Monthly
1.79%
Yearly
10.67%
Q2 Forecast
82.35

Edwards Lifesciences reported $227.5M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
Abbott USD 4.24B 117M Dec/2025
Artivion USD 16.04M 454K Dec/2025
AtriCure USD 78.4M 3.56M Dec/2025
Baxter International USD 999M 46M Dec/2025
Becton, Dickinson and Co. USD 6.14B 4.16B Dec/2025
Boston Scientific USD 1.14B 142M Dec/2025
Cooper Companies USD 225.8M 74.6M Dec/2025
Dexcom USD 1.83B 1.38B Dec/2025
Edwards Lifesciences USD 227.5M 62.5M Dec/2025
Globus Medical USD 98.85M 11.62M Dec/2025
ICU Medical USD 154.37M 17.38M Dec/2025
Inogen USD 21.22M 684K Sep/2025
Insulet USD 75M 26.8M Dec/2025
Integra LifeSciences USD 95.73M 3.42M Dec/2025
Intuitive Surgical USD 1.85B 68.6M Mar/2026
J&J USD 10.46B 1.53B Mar/2026
Masimo USD 103M 14.9M Dec/2025
Medtronic USD 2.57B 12M Dec/2025
Merit Medical Systems USD 60.55M 4.19M Dec/2025
Stryker USD 1.5B 56M Sep/2025
Tandem Diabetes Care USD 47.07M 414K Dec/2025
Teleflex USD 130.2M 35.71M Dec/2025
Zimmer Biomet Holdings USD 303M 12.3M Dec/2025